Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress
This completed clinical trial assessed serum bile acid profiles in individuals with type 2 diabetes and explored associations between bile a…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
Clinical trial update on the long-term use of Alogliptin/Pioglitazone (Liovel) combination tablets in adults with type 2 diabetes mellitus; …
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes [NA]
A completed clinical study evaluating myocardial regional function under dobutamine stress echocardiography in individuals with metabolic sy…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Hyaluronic Acid With Scaling & Root Planing In Chronic Periodontitis Patients With Diabetes Mellitus Type 2 [NA]
A completed clinical trial evaluated the use of hyaluronic acid alongside scaling and root planing in chronic periodontitis patients who hav…
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study evaluating pharmacokinetics, safety and efficacy of albiglutide in pediatric patients with type 2 diabetes has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-01-16Clinical Trial Update: Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin [Phase 4]
A Phase 4 trial comparing aggressive versus conservative blood glucose control in hospitalized patients with Type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>
Clinical trial update on pioglitazone tablets from a glycemic control survey in type 2 diabetes patients with prior cerebral infarction; com…
-
FDA approval · 2019-01-15FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Trulicity (dulaglutide) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole [Phase 4]
Phase 4 trial update examining adiposity and metabolic measures when switching from atypicals to aripiprazole in schizophrenia patients, wit…
-
FDA approval · 2019-01-14FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for metformin hydrochloride from Mylan Pharmaceuticals Inc., a generic metformin product. Metfor…
-
FDA approval · 2019-01-14FDA Approved: METFORMIN ER 500 MG — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for METFORMIN ER 500 MG from Quallent Pharmaceuticals Health LLC, with METFORMIN ER 750 MG listed as…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey [Phase 4]
Phase 4 trial evaluating initiation and titration of insulin glargine (U300) in insulin-naïve patients with type 2 diabetes controlled on or…
-
CLINICAL_TRIALS research · 2019-01-11Clinical Trial Update: A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
This is a completed non-interventional trial evaluating the safety and effectiveness of Trajenta (linagliptin) 5 mg daily in Korean patients…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Vitamin D for Established Type 2 Diabetes (DDM2) [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial investigating vitamin D supplementation in established Type 2 Diabetes with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy [Phase 2]
Phase 2 add-on trial of MLR-1023 in adults with uncontrolled type 2 diabetes on metformin.
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial update comparing once-weekly semaglutide to daily sitagliptin as add-on to metformin/TZD in type 2 diabetes; results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing safety and efficacy of semaglutide as monotherapy or with one oral antidiabetic drug in Japanese subjects with type …
-
CLINICAL_TRIALS trial_result · 2019-01-07Clinical Trial Update: Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA [Phase 4]
Phase 4 trial update on long-term safety and efficacy of empagliflozin added to a GLP-1 receptor agonist in adults with type 2 diabetes mell…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2) [Phase 4]
Phase 4 trial evaluating testosterone replacement therapy in hypogonadal men with type 2 diabetes; completed study.
-
FDA approval · 2019-01-04FDA Approved: GLYBURIDE — Original Application (Modavar Pharmaceuticals LLC)
The FDA approved the original ANDA for glyburide (GLYBURIDE) from Modavar Pharmaceuticals LLC, enabling generic access to this sulfonylurea.…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction [Phase 3]
Phase 3 trial evaluating the effect of dapagliflozin on progression from prediabetes to type 2 diabetes in subjects with myocardial infarcti…
-
FDA approval · 2019-01-02FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Precision Dose, Inc.)
FDA approved a supplemental application for metformin hydrochloride from Precision Dose, Inc., under the existing NDA.
-
FDA approval · 2019-01-02FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metformin hydrochloride by Aurobindo Pharma Limited under ANDA079118. This action confirms appro…
-
FDA approval · 2018-12-27FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)
The FDA approved Qingdao BAHEAL Pharmaceutical Co., Ltd.'s metformin hydrochloride extended-release tablets under an Original Application (A…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria [Phase 3]
A Phase 3 clinical trial evaluating CS-3150 in hypertensive patients with type 2 diabetes and albuminuria has completed.